Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homocysteine methylation is a crucial biochemical pathway responsible for regenerating methionine from homocysteine. This process is vital for maintaining the cellular methylation pool and regulating various biological processes, including DNA methylation, protein methylation, and lipid methylation. The pathway involves key enzymes like methionine synthase and betaine-homocysteine methyltransferase, and requires cofactors such as folate, vitamin B12, and betaine. Dysregulation of homocysteine methylation can lead to hyperhomocysteinemia and is associated with increased risks of cardiovascular disease, neurodegenerative disorders, and other chronic conditions. It has also epigenetic implications due to SAM/SAH imbalances.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homocysteine Methylation (None).